- Reduced price
Reference: 56391
Crash Course Endocrinology: Updated Print + digital version Edition
Author: Daniel Horton-Szar
Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details
Pay with a quick bank transfer, payment card or cash on delivery. Click for more details
If you are a consumer, you can return the goods within 14 days. Click for more details
Data sheet
Table of Contents
1. CHEMOTHERAPY AGENTS –WILL INCLUDE A SUMMARY OF EACH TYPE BEFORE CLINICAL QUESTIONS
a. Cytotoxic
b. Targeted Agents
c. Hormonal Agents
d. Immunotherapy
2. RADIATION THERAPY
3. MOST COMMON HEME QUESTIONS
a. Anemia
b. Thrombocytopenia
c. Thrombosis
d. Transfusion reactions
4. SCREENING
a. Breast cancer
b. Cervical
c. Colon Cancer
d. Prostate
e. Lung Cancer
5. BREAST CANCER
a. Non-invasive
b. Invasive
c. Inflammatory breast cancer
d. Phyllodes
e. Pagets
6. HEAD AND NECK
7. THYROID CARCINOMAS
8. GI CANCER
a. Esophagus
b. Gastric/GEJ
c. Colon
d. Rectal
e. Anus
f. Pancreas
g. Cholangiocarcinoma
h. Hepatocellular Carcinoma
i. Neuroendocrine tumors
9. GU CANCER
a. Bladder
b. Kidney
c. Prostate
d. Testicular
10. GYNECOLOGICAL MALIGNANCIES
a. Cervical
b. Endometrial
c. Ovarian
d. Uterine
11. MELANOMAS
12. THORACIC
a. Small cell lung cancer
b. Non-small cell lung cancer
13. SARCOMAS
14. OCCULT PRIMARY
15. BASICS OF PATHOLOGY AND HEMATOLOGY
a. Bone Marrow, Flow Cytometry, Cytogenetics, Molecular testing.
b. Solid tumor pathology basics
16. BASICS OF BONE MARROW TRANSPLANTATION
a. Types (Allo, Auto)
b. Indications
17. LYMPHOMAS
a. Hodgkins Lymphoma
i. Classical HL
ii. Nodular lymphocyte-predominant HL
b. Non-Hodgkins Lymphoma
i. B-cell NHL
a) Diffuse large B-cell Lymphoma (DLBCL)
b) Follicular Lymphoma
c) Mantle Cell Lymphoma (MCL)
d) Small Lymphocytic Lymphoma (SLL)
e) Primary CNS Lymphoma
f) Primary Mediastinal Lymphoma (PML)
g) Burkitt Lymphoma (BL)
h) Primary Effusion Lymphoma
i) Double-hit Lymphoma
j) Primary Effusion Lymphoma (PEL)
ii. T-Cell NHL
a) Peripheral T-cell Lymphoma (PTCL)
b) Primary Cutaneous T-cell Lymphoma
c) Anaplastic Large Cell Lymphoma (ALCL)
d) Post-Transplant Lymphoproliferative
18. LEUKEMIAS
a) Acute Leukemias
i. Acute Myeloid Leukemia (AML)
ii. APL
i. Acute Lymphoblastic Leukemia (ALL)
b) Chronic Leukemias:
i. Chronic Myeloid Leukemia (CML)
ii. Chronic Lymphocytic Leukemia (CLL)
iii. Hairy Cell Leukemia
19. PLASMA CELL DISORDERS:
a. Monoclonal Gammopathy of Undetermined Significance (MGUS)
b. Multiple Myeloma (MM)
c. Lymphoplasmacyctic Lymphoma (including Waldenstroms Macroglobulinemia)
d. Solitary Plasmacytoma
e. AL Amyloidosis
f. POEMS Syndrome
20. MYELOPROLIFERATIVE NEOPLASMS
a. Polycythemia Vera (PV)
b. Essential Thrombocythemia (ET)
c. Primary Myelofibrosis (PMF)
d. Systemic Mastocytosis (SM)
21. MYELODYSPLASTIC SYNDROMES
22. GUIDELINES FOR SUPPORTIVE CARE
a. Management of Side Effects of Chemotherapy
i. Myelosuppression
ii. Nausea
iii. Vomiting
iv. Diarrhea
v. Mucositis
vi. Anorexia, weight loss
b. Management of Cancer-related pain
c. Management of Cachexia
23. ONCOLOGIC EMERGENCIES
a. Neutropenic Fever
b. Spinal Cord Compression
c. Tumor Lysis Syndrome
d. Superior vena cava syndrome
e. Hypercalcemia of malignancy
f. Hyperleukocytosis and leukostasis
24. GENETIC AND FAMILIAL ASSESSMENT FOR FAMILIAL CANCER SYNDROMES
25. END OF LIFE
Reference: 56391
Author: Daniel Horton-Szar
Reference: 56392
Author: Daniel Horton-Szar
Reference: 56393
Author: Daniel Dr Horton-Szar
Reference: 77951
Author: Fong Nigel Jie Ming
Reference: 80406
Author: Sotirios A. Tsementzis